Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 6Sarcoma 3Gynecologic 3Gastrointestinal 3Breast 3Thoracic 1Head & Neck 1

Conditions

Sarcoma 2Sarcoma, Ewing 1

Interventions

Specimen Handling 36Magnetic Resonance Spectroscopy 31Cyclophosphamide 26Doxorubicin 23Biopsy 22pembrolizumab 21Temozolomide 21X-Rays 17Radiotherapy 17Radiation 16Nivolumab 13atezolizumab 12Vincristine 12Phantoms, Imaging 12Irinotecan 12Ifosfamide 12Gemcitabine 12fludarabine 11cabozantinib 10liposomal doxorubicin 8Surgical Procedures, Operative 8Ipilimumab 8Etoposide 8Bevacizumab 8Paclitaxel 7Immunoglobulin G 7Carboplatin 7palbociclib 6olaparib 6fludarabine phosphate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Radiation Dose Hypofractionation × Sarcoma × 90 days × Clear all
NCT07188532 2026-06-04

BEAR

Mayo Clinic

Phase NA Recruiting
141 enrolled
Sarcoma

Sarcoma, Ewing

NCT03972930 2026-05-12

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

University of Wisconsin, Madison

Phase 2 Active not recruiting
48 enrolled 10 charts
Sarcoma

Sarcoma

NCT05917301 2026-04-17

PRONTO

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
40 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡